09/06/2026
🧬 Type 2 Diabetes, Inflammation and Salivary Gland Dysfunction
Hyposalivation and xerostomia are frequent oral complications of type 2 diabetes, yet the mechanisms underlying salivary gland dysfunction remain incompletely defined. This study in a male Wistar rat model of type 2 diabetes showed reduced salivary flow and α-amylase activity together with increased salivary inflammatory biomarkers, disturbed extracellular matrix remodeling, and higher apoptotic activity, with the parotid glands appearing particularly affected. These findings support inflammation-driven salivary gland hypofunction as a biologically plausible pathway in diabetes and may inform future translational studies, biomarker research and preventive oral care strategies for patients with metabolic disease.
Specific implications and practical applications:
🔸The study strengthens the rationale for considering salivary gland dysfunction as part of the oral complication profile of type 2 diabetes.
🔸The parotid gland may be a particularly relevant target for future mechanistic studies on diabetic salivary hypofunction.
🔸Increased levels of cytokines, chemokines, growth factors, pro-inflammatory enzymes, MMPs, and lysosomal exoglycosidases suggest that inflammation and extracellular matrix remodeling may act together in glandular impairment.
🔸The findings support further investigation of salivary biomarkers as non-invasive indicators of diabetes-related oral tissue dysfunction.
🔸Although based on an animal model, the results may help guide future clinical research on xerostomia, hyposalivation, caries risk, periodontal vulnerability, and oral quality of life in patients with type 2 diabetes.
🔗 Read more: https://dmp.umw.edu.pl/en/article/2026/63/1/145/